The stock has jumped 40 per cent in the intra-day trade on Monday after the firm received approval for Favipiravir’s (Fabiflu), a potential Covid-19 drug, by the Drug Controller General of India
Iconic One Theme | Powered by Wordpress
The stock has jumped 40 per cent in the intra-day trade on Monday after the firm received approval for Favipiravir’s (Fabiflu), a potential Covid-19 drug, by the Drug Controller General of India